Report Detail
Global Cancer Biopharmaceuticals Market Growth (Status and Outlook) 2019-2024
- RnM3411886 |
- 13 May, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Cancer drugs are the primary concern in terms of drug development trends.
According to this study, over the next five years the Cancer Biopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cancer Biopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cancer Biopharmaceuticals market by product type, application, key companies and key regions.
This study considers the Cancer Biopharmaceuticals value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Biologics
Biosimilars
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Liquid Cancers
Solid Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Johnson & Johnson
Pfizer
Novartis
Merck
GlaxoSmithKline
Eli Lilly
Agios Pharmaceuticals
Bristol-Myers Squibb
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Biopharmaceuticals market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Biopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Cancer Biopharmaceuticals players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Biopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cancer Biopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cancer Biopharmaceuticals Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cancer Biopharmaceuticals Market Size 2014-2024
- 2.1.2 Cancer Biopharmaceuticals Market Size CAGR by Region
- 2.2 Cancer Biopharmaceuticals Segment by Type
- 2.2.1 Biologics
- 2.2.2 Biosimilars
- 2.3 Cancer Biopharmaceuticals Market Size by Type
- 2.3.1 Global Cancer Biopharmaceuticals Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Cancer Biopharmaceuticals Market Size Growth Rate by Type (2014-2019)
- 2.4 Cancer Biopharmaceuticals Segment by Application
- 2.4.1 Liquid Cancers
- 2.4.2 Solid Cancers
- 2.5 Cancer Biopharmaceuticals Market Size by Application
- 2.5.1 Global Cancer Biopharmaceuticals Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Cancer Biopharmaceuticals Market Size Growth Rate by Application (2014-2019)
3 Global Cancer Biopharmaceuticals by Players
- 3.1 Global Cancer Biopharmaceuticals Market Size Market Share by Players
- 3.1.1 Global Cancer Biopharmaceuticals Market Size by Players (2017-2019)
- 3.1.2 Global Cancer Biopharmaceuticals Market Size Market Share by Players (2017-2019)
- 3.2 Global Cancer Biopharmaceuticals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cancer Biopharmaceuticals by Regions
- 4.1 Cancer Biopharmaceuticals Market Size by Regions
- 4.2 Americas Cancer Biopharmaceuticals Market Size Growth
- 4.3 APAC Cancer Biopharmaceuticals Market Size Growth
- 4.4 Europe Cancer Biopharmaceuticals Market Size Growth
- 4.5 Middle East & Africa Cancer Biopharmaceuticals Market Size Growth
5 Americas
- 5.1 Americas Cancer Biopharmaceuticals Market Size by Countries
- 5.2 Americas Cancer Biopharmaceuticals Market Size by Type
- 5.3 Americas Cancer Biopharmaceuticals Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cancer Biopharmaceuticals Market Size by Countries
- 6.2 APAC Cancer Biopharmaceuticals Market Size by Type
- 6.3 APAC Cancer Biopharmaceuticals Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cancer Biopharmaceuticals by Countries
- 7.2 Europe Cancer Biopharmaceuticals Market Size by Type
- 7.3 Europe Cancer Biopharmaceuticals Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cancer Biopharmaceuticals by Countries
- 8.2 Middle East & Africa Cancer Biopharmaceuticals Market Size by Type
- 8.3 Middle East & Africa Cancer Biopharmaceuticals Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Cancer Biopharmaceuticals Market Forecast
- 10.1 Global Cancer Biopharmaceuticals Market Size Forecast (2019-2024)
- 10.2 Global Cancer Biopharmaceuticals Forecast by Regions
- 10.2.1 Global Cancer Biopharmaceuticals Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Cancer Biopharmaceuticals Forecast by Type
- 10.8 Global Cancer Biopharmaceuticals Forecast by Application
11 Key Players Analysis
- 11.1 Sanofi
- 11.1.1 Company Details
- 11.1.2 Cancer Biopharmaceuticals Product Offered
- 11.1.3 Sanofi Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Sanofi News
- 11.2 Johnson & Johnson
- 11.2.1 Company Details
- 11.2.2 Cancer Biopharmaceuticals Product Offered
- 11.2.3 Johnson & Johnson Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Johnson & Johnson News
- 11.3 Pfizer
- 11.3.1 Company Details
- 11.3.2 Cancer Biopharmaceuticals Product Offered
- 11.3.3 Pfizer Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Pfizer News
- 11.4 Novartis
- 11.4.1 Company Details
- 11.4.2 Cancer Biopharmaceuticals Product Offered
- 11.4.3 Novartis Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Novartis News
- 11.5 Merck
- 11.5.1 Company Details
- 11.5.2 Cancer Biopharmaceuticals Product Offered
- 11.5.3 Merck Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Merck News
- 11.6 GlaxoSmithKline
- 11.6.1 Company Details
- 11.6.2 Cancer Biopharmaceuticals Product Offered
- 11.6.3 GlaxoSmithKline Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 GlaxoSmithKline News
- 11.7 Eli Lilly
- 11.7.1 Company Details
- 11.7.2 Cancer Biopharmaceuticals Product Offered
- 11.7.3 Eli Lilly Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Eli Lilly News
- 11.8 Agios Pharmaceuticals
- 11.8.1 Company Details
- 11.8.2 Cancer Biopharmaceuticals Product Offered
- 11.8.3 Agios Pharmaceuticals Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Agios Pharmaceuticals News
- 11.9 Bristol-Myers Squibb
- 11.9.1 Company Details
- 11.9.2 Cancer Biopharmaceuticals Product Offered
- 11.9.3 Bristol-Myers Squibb Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Bristol-Myers Squibb News
- 11.10 AstraZeneca
- 11.10.1 Company Details
- 11.10.2 Cancer Biopharmaceuticals Product Offered
- 11.10.3 AstraZeneca Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 AstraZeneca News
- 11.11 Mylan
- 11.12 LEO Pharma
- 11.13 Boehringer Ingelheim
- 11.14 Alexion Pharmaceuticals
- 11.15 Elusys Therapeutics
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cancer Biopharmaceuticals . Industry analysis & Market Report on Cancer Biopharmaceuticals is a syndicated market report, published as Global Cancer Biopharmaceuticals Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Cancer Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
